A leading multidisciplinary forum for the global immuno-oncology community, this international meeting will bring together researchers, clinicians and other stakeholders to expand the frontiers of immuno-oncology through advanced therapies, with a strong focus on addressing the current scientific and clinical barriers to effective cancer immunotherapy.
The half-day primer program will cover a wide range of clinical and translational topics across the field of IO. Program information coming soon.
This program is jointly provided by the Society for Immunotherapy of Cancer (SITC) and the European Society for Medical Oncology (ESMO).